Zhang Y, Zhao X, Dong X, Zhang Y, Zou H, Jin Y, et al
Enter GLP-1 RAs for obesity management and cardiovascular risk reduction
Ozempic is FDA-approved for two indications: To improve blood sugar control in adults with type 2 diabetes To reduce the risk of major cardiovascular events, such as heart attack or stroke, in adults with type 2 diabetes and heart disease Wegovy is also FDA-approved for two indications: To reduce body weight and maintain weight loss in adults and children ages 12 and up with obesity, as well as in adults with overweight and at least one weight-related health condition To reduce the risk of major cardiovascular events, such as heart attack or stroke, in adults with heart disease and either obesity or overweight Rybelsus is FDA-approved to treat type 2 diabetes by improving blood sugar control
When drug manufacturers cause severe pharmaceutical injuries like gastroparesis, they should be held accountable and financially responsible for failing to test their drugs properly
This is especially important if you are also taking an SGLT2 inhibitor
These frequencies of studies on AFs displayed that these mycotoxins received much attention from academia and clinical sectors due to their health hazardous risks